lobbying_activities: 2632098

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2632098	51b771a6-ab1f-47f3-8fcc-ee2a9267afe2	Q2	AMERICAN SOCIETY OF NEPHROLOGY	80656	AMERICAN SOCIETY OF NEPHROLOGY	2021	second_quarter	HCR	FY22 Congressional appropriations: -Increase NIH funds overall of at least $46.111 billion, providing a proportionate increase for the NIDDK of at least $157 million -Provide supplemental emergency funding of $10 billion for NIH and ensure dedicated support for the NIDDK to enable critical COVID-related research and to support research recovery from the impact of the pandemic. -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations kidney therapeutics and technologies Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Increase access to home dialysis through at-home support, increased education, and removal of other barriers to at-home care	Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE		40000	0	0	2021-06-28T16:35:43.747000-04:00